Benzodiazepine Use and Risk of Developing Alzheimer's Disease: A Case-Control Study Based on Swiss Claims Data (Q31154313)

29 June 2017

title

Benzodiazepine Use and Risk of Developing Alzheimer's Disease: A Case-Control Study Based on Swiss Claims Data (English)

1 reference

29 June 2017

0 references

Matthias Schwenkglenks

4

object named as

Matthias Schwenkglenks

0 references

author name string

Fabienne A Biétry

1

1 reference

29 June 2017

Alena M Pfeil

2

1 reference

29 June 2017

Oliver Reich

3

1 reference

29 June 2017

Christoph R Meier

5

1 reference

29 June 2017

publication date

11 January 2017

1 reference

29 June 2017

1 reference

29 June 2017

volume

31

1 reference

29 June 2017

issue

3

1 reference

29 June 2017

page(s)

245-251

1 reference

Epidemiology of Alzheimer disease

29 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS40263-016-0404-X

The peripheral benzodiazepine receptors: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-016-0404-X

Effectiveness and safety of benzodiazepines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-016-0404-X

Benzodiazepines for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-016-0404-X

Effects of combined alcohol and benzodiazepine: A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-016-0404-X

Polydrug abuse: a review of opioid and benzodiazepine combination use

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-016-0404-X

Benzodiazepine Dependence A Review of the Evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-016-0404-X

Benzodiazepine and opioid use and the duration of intensive care unit delirium in an older population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-016-0404-X

Cognitive and sedative effects of benzodiazepine use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-016-0404-X

Potentially inappropriate prescribing in older people with dementia in care homes: a retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-016-0404-X

Trends in use of antipsychotics in elderly patients with dementia: Impact of national safety warnings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-016-0404-X

The association between dementia and long-term use of benzodiazepine in the elderly: nested case-control study using claims data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-016-0404-X

Risk of dementia in patients with insomnia and long-term use of hypnotics: a population-based retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-016-0404-X

Benzodiazepine use and risk of dementia: a nested case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-016-0404-X

Benzodiazepine use and risk of dementia: prospective population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-016-0404-X

Benzodiazepine use and risk of Alzheimer's disease: case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-016-0404-X

Benzodiazepine Use and Risk of Developing Alzheimer's Disease or Vascular Dementia: A Case-Control Analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-016-0404-X

Benzodiazepine use and risk of incident dementia or cognitive decline: prospective population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-016-0404-X

Prodromal Alzheimer's disease: successive emergence of the clinical symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-016-0404-X

Neuropsychiatric symptoms in the prodromal stages of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-016-0404-X

Late-life depression, mild cognitive impairment, and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-016-0404-X

The problem of "protopathic bias" in case-control studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-016-0404-X

Benzodiazepine use among patients with schizophrenia in Taiwan: a nationwide population-based survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-016-0404-X

Predictors of High Profit and High Deficit Outliers under SwissDRG of a Tertiary Care Center

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-016-0404-X

Rivastigmine for dementia associated with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-016-0404-X

Rivastigmine for gait stability in patients with Parkinson's disease (ReSPonD): a randomised, double-blind, placebo-controlled, phase 2 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-016-0404-X

Neuropsychological predictors of conversion to probable Alzheimer disease in elderly with mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-016-0404-X

The Prevalence and Incidence of Dementia with Lewy Bodies: a Systematic Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-016-0404-X

Benzodiazepine use and risk of dementia: evidence from the Caerphilly Prospective Study (CaPS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-016-0404-X

Benzodiazepine dependence and withdrawal: a review of the syndrome and its clinical management.

21 January 2018

1 reference

12 December 2020

Effect of benzodiazepine discontinuation on dementia risk

1 reference

12 December 2020

American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults

1 reference

12 December 2020

Benzodiazepine use in the United States

1 reference

12 December 2020

10.1007/S40263-016-0404-X

Identifiers

DOI

1 reference

Dimensions Publication ID

29 June 2017

1001020656

0 references

1 reference